Nivolumab monotherapy in metastatic urothelial cancer (mUC): Efficacy (by PD-L1 expression) and safety results from the CheckMate 032 study Meeting Abstract
| Authors: | Jaeger, D.; Sharma, P.; Bono, P.; Kim, J.; Spiliopoulou, P.; Calvo, E.; Pillai, R. N.; Ott, P. A.; de Braud, F.; Morse, M.; Le, D.; Chan, E.; Harbison, C.; Lin, C. S.; Tschaika, M.; Azrilevich, A.; Rosenberg, J. |
| Abstract Title: | Nivolumab monotherapy in metastatic urothelial cancer (mUC): Efficacy (by PD-L1 expression) and safety results from the CheckMate 032 study |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 39 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2016 Oct 14-18 |
| Meeting Location: | Leipzig, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2016-10-01 |
| Start Page: | 269 |
| Language: | English |
| ACCESSION: | WOS:000385691300671 |
| PROVIDER: | wos |
| DOI: | 10.1159/000449050 |
| Notes: | Meeting Abstract; P888 -- Source: Wos |
